Serious side effects, such as pancreatitis or thyroid issues, are rare
Semaglutide can interact with other medications, so it's crucial to inform your healthcare provider about all medications you are taking, including prescription, over-the-counter, and herbal supplements
Studies suggest the body often reacts differently than expected
Tirzepatide is a synthetic peptide studied for its activity at both GIP and GLP-1 receptors
The participants were divided into the following experimental groups or a placebo group: 1 mg of retatrutide (subcutaneously) 4 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 4 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 12 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg Here are the detailed results of the trial at 24 weeks and 48 weeks: Phase II clinical trial projects promising results of retatrutide in weight management